SCHEMBL321199

SCHEMBL321199

COn1ccc2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 4/20 0.45
CCND1 P24385 4/20 0.45
NOTUM Q6P988 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
BIRC5 O15392 1/20 0.38
CA12 O43570 2/20 0.38
CA9 Q16790 2/20 0.38
ALDH1A1 P00352 2/20 0.38
BRD4 O60885 1/20 0.38
BRPF1 P55201 1/20 0.38
KAT2B Q92831 1/20 0.38
BRD9 Q9H8M2 1/20 0.38
MAPT P10636 1/20 0.38
KMT2A Q03164 2/20 0.37
TSHR P16473 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
RAB9A P51151 1/20 0.37
PRKD3 O94806 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29614841 1.00 CDK4 (0.45) CDK4CCND1NOTUMSMN1; SMN2HTR2A
Hydrochloric Acid SCHEMBL7218572 0.98 CDK4 (0.43) CDK4CCND1NOTUMSMN1; SMN2HTR2A
Formamide SCHEMBL28452735 0.89 NOTUM (0.41) CDK4CCND1NOTUMSMN1; SMN2HTR2A
Trifluoroacetic Acid SCHEMBL7401383 0.83 NOTUM (0.44) NOTUMSMN1; SMN2ALDH1A1KMT2ATSHR
SCHEMBL10932323 0.83 CDK4 (0.42) CDK4CCND1NOTUMHTR2AHTR2C
SCHEMBL3576716 0.78 CDK4 (0.47) CDK4CCND1NOTUMHTR2AHTR2C
SCHEMBL30233726 0.78 CDK4 (0.47) CDK4CCND1NOTUMHTR2AHTR2C
SCHEMBL4288131 0.77 CDK4 (0.45) CDK4CCND1NOTUMHTR2AHTR2C
SCHEMBL22769564 0.77 CDK4 (0.45) CDK4CCND1NOTUMBIRC5ALDH1A1
SCHEMBL6530754 0.77 CDK4 (0.45) CDK4CCND1NOTUMHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 288 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122004225-A Application of 1-methoxyindole in preventing and treating nematodes and nematicide 浙江大学 2026-05-12 CN claimed
US-20260047577-A1 USE OF 1-METHOXYINDOLE FOR REPELLING AND/OR KILLING PESTS UNIV ZHEJIANG (CN) 2026-02-19 US claimed
CN-119014415-A Application of 1-methoxyindole in repelling and/or killing pests 浙江大学 2024-11-26 CN claimed
CN-115650973-B Synthesis method and application of NSC69187 derivative compound 南方医科大学 2024-04-16 CN claimed
CN-116554272-A Novel anti-wrinkle hexapeptide compound and preparation method thereof 杭州湃肽生化科技有限公司 2023-08-08 CN claimed
US-20230192660-A1 Protease Inhibitors for Treatment or Prevention of Coronavirus Disease UNIV LELAND STANFORD JUNIOR (US) 2023-06-22 US claimed
EP-4146267-A1 PROTEASE INHIBITORS FOR TREATMENT OR PREVENTION OF CORONAVIRUS DISEASE The Board of Trustees of the Leland Stanford Junior University (US) 2023-03-15 EP claimed
CN-110840896-B Preparation method and application of dihydro quinazolinone medicine 三峡大学 2022-05-03 CN claimed
WO-2021226546-A1 PROTEASE INHIBITORS FOR TREATMENT OR PREVENTION OF CORONAVIRUS DISEASE THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2021-11-11 WO claimed
CN-111303125-A Methoxy-substituted indole-pyrimidine compound and preparation method thereof 天津法莫西医药科技有限公司 2020-06-19 CN claimed
EP-3490983-A1 DIMETHOXYPHENYL SUBSTITUTED INDOLE COMPOUNDS AS TLR7, TLR8 OR TLR9 INHIBITORS Bristol-Myers Squibb Company (US) 2019-06-05 EP claimed
WO-2018026620-A1 DIMETHOXYPHENYL SUBSTITUTED INDOLE COMPOUNDS AS TLR7, TLR8 OR TLR9 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-02-08 WO claimed
US-7847152-B2 Use of tryptophan indole and anthranilate analogs as plant transformation selection agents THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2010-12-07 US claimed
US-20040167119-A1 2-(aminomethyl) arylamide analgesics PHARMACOPEIA, INC (US) 2004-08-26 US claimed
WO-2004071445-A2 2-(AMINOMETHYL)ARYLAMIDE ANALGESICS PHARMACOPEIA DRUG DISCOVERY, INC. (US) 2004-08-26 WO claimed
EP-0833818-A1 CB 2? RECEPTOR AGONIST COMPOUNDS SANOFI (FR) 1998-04-08 EP claimed
EP-0574494-A4 INDOLES USEFUL AS PLATELET ACTIVATING FACTOR ANTAGONISTS ABBOTT LAB (US) 1994-07-06 EP claimed
EP-0574494-A1 INDOLES USEFUL AS PLATELET ACTIVATING FACTOR ANTAGONISTS ABBOTT LABORATORIES (US) 1993-12-22 EP claimed
WO-1992014732-A1 INDOLES USEFUL AS PLATELET ACTIVATING FACTOR ANTAGONISTS ABBOTT LABORATORIES (US) 1992-09-03 WO claimed
US-4076537-A Light-sensitive materials containing organo tellurium or selenium compounds and sensitizers FUJI PHOTO FILM CO., LTD. (JA) 1978-02-28 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192660-A1 Protease Inhibitors for Treatment or Prevention of Coronavirus Disease ACE, ACE2, PEPD CDK4 1537/4885CCND1 3664/4885NOTUM 239/4885
US-20260047577-A1 USE OF 1-METHOXYINDOLE FOR REPELLING AND/OR KILLING PESTS MIF, IDO1, IDO2 CDK4 4041/4885CCND1 2257/4885NOTUM 368/4885
US-20040167119-A1 2-(aminomethyl) arylamide analgesics OPRL1, OPRM1, OPRK1 CDK4 3123/4885CCND1 3963/4885NOTUM 2583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.